In patients with newly diagnosed multiple myeloma (MM) who are not eligible for stem cell transplant, the regimen of isatuximab plus lenalidomide, dexamethasone, and bortezomib (also known as Isa-VRd) ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Neoadjuvant epacadostat (INCB024360) combined with short course radiotherapy in patients with locally advanced rectal cancer: Efficacy and safety from a phase 2 trial. Disease-free survival by ...

Fabrinet engages in the provision of optical packaging and electronic manufacturing services to original equipment manufacturers. The firm's engineering services include process design, failure ...